Nicole Lambert
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
Nicole Lambert is currently an Independent Director at Arcus Biosciences, Inc. since 2021 and President at Myriad Genetic Laboratories, Inc. Formerly, Ms. Lambert was Chief Operating Officer at Myriad Genetics, Inc. from 2022 to 2023.
Education includes undergraduate studies at Boston College and graduate studies at Icahn School of Medicine at Mount Sinai.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARCUS BIOSCIENCES, INC. 0,03 % | 11/06/2026 | 43.000 ( 0,03 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Director/Miembro de la Junta | 03/08/2021 |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides cancer predisposition testing services | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
| MYRIAD GENETICS, INC. | Director de Operaciones | 31/10/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides cancer predisposition testing services | Commercial Services |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.